Vit Vasista

(Mr. Vittal Vasista)

Currently holds a position at Regenxbio Inc

Positions
Position Company Period
Chief Financial Officer, Senior Vice President Regenxbio Inc Jan. 1, 2019 -
Chief Financial Officer Regenxbio Inc Jan. 1, 2017 - Jan. 1, 2019
Chief Financial Officer Regenxbio Inc Aug. 1, 2009 - Jan. 1, 2017
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value
Number of shares Price Total value Details
2022-08-31 2022-08-30
US Regenxbio Inc (RGNX)
PS Planned sale
2,400 -1.7%
30.24
72,573 USD
2,400 -1.7% 30.24 72,573 USD
2022-08-08 2022-08-05
US Regenxbio Inc (RGNX)
PS Planned sale
17,280 -11.2%
35.19
608,035 USD
17,280 -11.2% 35.19 608,035 USD
2022-08-08 2022-08-04
US Regenxbio Inc (RGNX)
PS Planned sale
400 -0.3%
35.00
14,000 USD
400 -0.3% 35.00 14,000 USD
2022-08-03 2022-08-01
US Regenxbio Inc (RGNX)
PS Planned sale
2,400 -1.5%
31.26
75,012 USD
2,400 -1.5% 31.26 75,012 USD
2022-07-15 2022-07-14
US Regenxbio Inc (RGNX)
PS Planned sale
468 -0.3%
30.00
14,040 USD
468 -0.3% 30.00 14,040 USD
2022-07-15 2022-07-13
US Regenxbio Inc (RGNX)
PS Planned sale
4,332 -2.7%
30.01
129,988 USD
4,332 -2.7% 30.01 129,988 USD
2021-01-20 2021-01-15
US Regenxbio Inc (RGNX)
PS Planned sale
252 -0.2%
50.04
12,610 USD
252 -0.2% 50.04 12,610 USD
2021-01-14 2021-01-14
US Regenxbio Inc (RGNX)
PS Planned sale
11,093 -8.9%
50.03
554,983 USD
11,093 -8.9% 50.03 554,983 USD
2021-01-14 2021-01-12
US Regenxbio Inc (RGNX)
PS Planned sale
4,200 -3.3%
50.01
210,042 USD
4,200 -3.3% 50.01 210,042 USD
2021-01-11 2021-01-08
US Regenxbio Inc (RGNX)
PS Planned sale
573 -0.4%
48.15
27,590 USD
573 -0.4% 48.15 27,590 USD
2021-01-11 2021-01-08
US Regenxbio Inc (RGNX)
PS Planned sale
2,208 -1.7%
47.49
104,858 USD
2,208 -1.7% 47.49 104,858 USD
2021-01-11 2021-01-08
US Regenxbio Inc (RGNX)
PS Planned sale
2,460 -1.8%
46.45
114,267 USD
2,460 -1.8% 46.45 114,267 USD
2021-01-11 2021-01-07
US Regenxbio Inc (RGNX)
PS Planned sale
10,998 -7.6%
50.00
549,900 USD
10,998 -7.6% 50.00 549,900 USD
2020-12-28 2020-12-24
US Regenxbio Inc (RGNX)
PS Planned sale
3,376 -2.5%
50.00
168,800 USD
3,376 -2.5% 50.00 168,800 USD
2020-12-28 2020-12-23
US Regenxbio Inc (RGNX)
PS Planned sale
21,124 -13.4%
50.01
1,056,411 USD
21,124 -13.4% 50.01 1,056,411 USD
2020-12-14 2020-12-11
US Regenxbio Inc (RGNX)
PS Planned sale
14,916 -8.6%
40.17
599,176 USD
14,916 -8.6% 40.17 599,176 USD
2020-12-14 2020-12-10
US Regenxbio Inc (RGNX)
PS Planned sale
22,584 -11.6%
40.06
904,715 USD
22,584 -11.6% 40.06 904,715 USD
2020-07-17 2020-07-15
US Regenxbio Inc (RGNX)
PS Planned sale
14,950 -7.1%
40.10
599,495 USD
14,950 -7.1% 40.10 599,495 USD
2020-05-12 2020-05-11
US Regenxbio Inc (RGNX)
PS Planned sale
500 -0.2%
40.00
20,000 USD
500 -0.2% 40.00 20,000 USD
2020-05-12 2020-05-08
US Regenxbio Inc (RGNX)
PS Planned sale
7,000 -3.3%
40.18
281,260 USD
7,000 -3.3% 40.18 281,260 USD
2020-04-27 2020-04-24
US Regenxbio Inc (RGNX)
PS Planned sale
12,000 -5.4%
40.11
481,320 USD
12,000 -5.4% 40.11 481,320 USD
2020-04-27 2020-04-23
US Regenxbio Inc (RGNX)
PS Planned sale
3,000 -1.3%
40.00
120,000 USD
3,000 -1.3% 40.00 120,000 USD
2020-02-12 2020-02-10
US Regenxbio Inc (RGNX)
PS Planned sale
14,129 -6.3%
50.12
708,145 USD
14,129 -6.3% 50.12 708,145 USD
2020-02-12 2020-02-10
US Regenxbio Inc (RGNX)
PS Planned sale
677 -0.3%
49.05
33,207 USD
677 -0.3% 49.05 33,207 USD
2020-02-07 2020-02-05
US Regenxbio Inc (RGNX)
PS Planned sale
300 -0.1%
50.00
15,000 USD
300 -0.1% 50.00 15,000 USD
2020-01-21 2020-01-17
US Regenxbio Inc (RGNX)
PS Planned sale
2,394 -1.1%
50.00
119,700 USD
2,394 -1.1% 50.00 119,700 USD
2020-01-10 2020-01-08
US Regenxbio Inc (RGNX)
PS Planned sale
5,100 -2.2%
41.92
213,792 USD
5,100 -2.2% 41.92 213,792 USD
2020-01-10 2020-01-08
US Regenxbio Inc (RGNX)
PS Planned sale
2,400 -1.0%
41.40
99,360 USD
2,400 -1.0% 41.40 99,360 USD
2019-03-25 2019-03-21
US Regenxbio Inc (RGNX)
PS Planned sale
1,700 -0.7%
61.31
104,227 USD
1,700 -0.7% 61.31 104,227 USD
2019-03-25 2019-03-21
US Regenxbio Inc (RGNX)
PS Planned sale
8,300 -3.5%
60.64
503,312 USD
8,300 -3.5% 60.64 503,312 USD
2019-03-07 2019-03-05
US Regenxbio Inc (RGNX)
PS Planned sale
3,068 -1.3%
60.01
184,111 USD
3,068 -1.3% 60.01 184,111 USD